ADC Therapeutics touts early Zynlonta results in marginal zone lymphoma, raises $105M through share sale
ADC Therapeutics touts early Zynlonta results in marginal zone lymphoma, raises $105M through share sale esagonowsky Mon, 05/06/2024 - 16:07
ADC Therapeutics touts early Zynlonta results in marginal zone lymphoma, raises $105M through share sale esagonowsky Mon, 05/06/2024 - 16:07
CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials fkansteiner Mon, 05/06/2024 - 15:30
How Pharma Can Harness Education to Transform the Health Journey jpiatt Mon, 05/06/2024 - 12:07
FDA flags 10 observations in another Form 483 for a Zydus plant zbecker Mon, 05/06/2024 - 10:59
Amneal agrees to $272.5M settlement to resolve opioid lawsuits kdunleavy Mon, 05/06/2024 - 10:36
Pfizer hires Citi analyst Andrew Baum to manage portfolio strategy, business development aliu Mon, 05/06/2024 - 10:35
BioNTech plots first wave of cancer launches in 2026 as COVID vaccine sales continue to disappoint fkansteiner Mon, 05/06/2024 - 10:31